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Autosomal-dominant dyskeratosis conge-
nita is associated with heterozygous muta-
tions in telomerase. To examine the dosage
effect of telomerase, we generated a line of
mTR+/mice on the CAST/EiJ background,
which has short telomeres. Interbreeding of
heterozygotes resulted in progressive telo-
mere shortening, indicating that limiting
telomerase compromises telomere mainte-
nance. In later-generation heterozygotes,
we observed a decrease in tissue renewal
capacity in the bone marrow, intestines,
and testes that resembled defects seen in
dyskeratosis congenita patients. The pro-
gressiveworseningofdiseasewithdecreas-
ing telomere lengthsuggests thatshort telo-
meres, not telomerase level, causestemcell
failure. Further,wild-typemicederived from
the late-generation heterozygous parents,
termed wt*, also had short telomeres and
displayed a germ cell defect, indicating
that telomere length determines these phe-
notypes. We propose that short telomeres
in mice that have normal telomerase levels
can cause an occult form of genetic dis-
ease.
INTRODUCTION
Autosomal-dominant dyskeratosis congenita is a disease of
stem cell failure due to telomere shortening. Affected individ-
uals exhibit symptoms that appear to be due to limited cellu-
lar reserves in tissues of high turnover. The primary cause ofCelldeath is due to complications of aplastic anemia or loss of
bone marrow stem cells (Dokal, 2000). Additionally, patients
develop abnormal skin pigmentation, premature graying, en-
teropathy, hypogonadism, and an increased cancer predis-
position. Families with autosomal-dominant dyskeratosis
congenita have mutations in telomerase components (Vul-
liamy et al., 2001; Armanios et al., 2005) and display antici-
pation, an earlier onset, and increasing severity of pheno-
types with each generation (Dokal, 2000; Vulliamy et al.,
2004). Telomere length is normally maintained by the en-
zyme telomerase. In the absence of telomerase, telomeres
shorten progressively due to the end replication problem
and telomere end processing (Reviewed in Greider, 1996;
Lingner and Cech, 1998). Telomerase adds a simple tandem
repeated sequence onto chromosome ends to balance this
shortening (Greider and Blackburn, 1985). The telomerase
core enzyme consists of two essential components: telo-
merase RNA, TR, which contains the template for repeat ad-
dition, and the catalytic component telomerase reverse tran-
scriptase or TERT (Lingner et al., 1997). In addition to families
with dyskeratosis congenita, mutations in both hTR and
hTERT have been described in familial and apparently spo-
radic cases of aplastic anemia where only hematologic phe-
notypes have been described (Vulliamy et al., 2002; Yama-
guchi et al., 2003, 2005). Since these phenotypes likely
represent a milder spectrum of dyskeratosis congenita, we
will refer to individuals with these phenotypes as having dys-
keratosis congenita. The loss of stem cells in these individu-
als with mutations in telomerase components has implicated
telomere length as a determinant of stem cell maintenance
(Dokal, 2000).
In the absence of telomerase, mice show progressive telo-
mere shortening with increased generations of interbreeding
(Blasco et al., 1997). In the first generation of telomerase de-
ficiency, mTR/ G1 mice on the C57BL/6J genetic back-
ground show no overt phenotypes. However with further
interbreeding, a series of phenotypes appear and worsen
as telomere shortening continues. This increased severity
of disease resembles the anticipation seen in autosomal-
dominant dyskeratosis congenita (Vulliamy et al., 2004).123, 1121–1131, December 16, 2005 ª2005 Elsevier Inc. 1121
Short telomeres in mice that lack telomerase cause apopto-
sis. This apoptosis is due to short dysfunctional telomeres
triggering a DNA-damage checkpoint response (Hemann
et al., 2001a; d’Adda di Fagagna et al., 2003; IJpma and
Greider, 2003; Hao et al., 2004). In mice, the apoptosis leads
to loss of germ cells and consequently decreased fertility
with each generation (Lee et al., 1998; Hemann et al.,
2001b).
Evidence from both human andmouse suggests that hap-
loinsufficiency for the telomerase RNA may cause telomere
shortening. A telomerase RNA truncation in an autosomal-
dominant dyskeratosis congenita family results in half of
the level of hTR and causes telomere shortening (Vulliamy
et al., 2001). Families with autosomal-dominant dyskeratosis
congenita show progressive telomere shortening with each
generation and a more severe and earlier onset of disease
(Vulliamy et al., 2004). Further, point mutations in hTR found
in dyskeratosis congenita and aplastic anemia patients show
reduced telomerase activity in vitro (Marrone et al., 2004;
Cerone et al., 2005; Ly et al., 2005). Similarly, haploinsuffi-
ciency is also observed when the protein component of telo-
merase, hTERT, is deficient (Armanios et al., 2005; Yamagu-
chi et al., 2005). In mice that are heterozygous formTR there
is reduced ability to elongate short telomeres in interspecies
crosses between strains with short telomeres and those with
long telomeres (Hathcock et al., 2002). Finally the mTERT
knockout mouse shows progressive telomere shortening
and an increased severity of phenotypes as seen in the
mTR/ mice (Erdmann et al., 2004). These data argue
that the level of telomerase activity, altered by either pertur-
bation in TR or TERT, affects the maintenance of telomere
length in vivo.
Telomere lengths show awide variation in the human pop-
ulation (Harley et al., 1990; Cawthon et al., 2003; Valdes
et al., 2005; Yamaguchi et al., 2005). Individual variation in
telomerase activity may account for part of this variability.
Such variability, even in cells that express telomerase, may
limit tissue renewal in normal individuals. For example, al-
though mature B and T cells, as well as CD34+ cells, express
telomerase (Morrison et al., 1996), telomere shortening oc-
curs in white blood cells with increasing age (Wynn et al.,
1998; Rufer et al., 1999; Hodes et al., 2002). This suggests
that the level of telomerase expressed in hematopoietic pro-
genitor cells is not sufficient to maintain telomere length. Re-
cent evidence also suggests an association between telo-
mere shortening and the risk of death due to age-related
diseases such as heart disease and infection (Cawthon
et al., 2003; Valdes et al., 2005).
To examine directly whether telomerase dosage affects
telomere length and disease phenotypes, we created mice
heterozygous for a null allele of telomerase RNA in a strain
that already has short telomeres. The telomere length distri-
bution in this CAST/EiJ strain is short and more homoge-
neous similar to human telomere lengths (Hemann and
Greider, 2000). Successive breeding of CAST/EiJ mTR+/
heterozygousmice resulted in progressive telomere shorten-
ing that was seen as organ failure in tissues of high turn-
over similar to dyskeratosis congenita patients. Further, we
find that the wild-type littermates, wt*, derived from later-1122 Cell 123, 1121–1131, December 16, 2005 ª2005 Elsevier Ingeneration heterozygotes that inherit short telomeres also
displayed phenotypes associated with telomere dysfunction.
We consider this phenomenon a form of occult genetic dis-
ease. We refer to thesemice as wt* since the genotype at the
responsible locus,mTR, is wild-type in the affected individu-
als who inherited short telomeres frommTR+/ heterozygous
parents. The presence of disease in wt* animals indicates
that loss of telomere function can occur in the presence of
normal levels of telomerase.
RESULTS
Progressive Telomere Shortening
of CAST/EiJ mTR/ and mTR+/ Animals
To critically examine whether haploinsufficiency for telomer-
ase causes telomere dysfunction, we crossed the mTR null
allele onto the CAST/EiJ genetic background that has a short
homogeneous telomere length distribution (see Experi-
mental Procedures). After establishing a line of CAST/EiJ
mTR+/ mice, these heterozygotes were intercrossed to
obtainmTR+/+,mTR+/, andmTR/ animals. The heterozy-
gous mice from this initial CAST/EiJ cross, designated
mTR+/ HG1, were then intercrossed to generate mTR+/
HG2 animals, which were further intercrossed to generate
mTR+/ HG3, HG4, HG5, and HG6 mice (Figure 1A). We
have previously shown that mTR+/ mice express half of
the steady-state level of telomerase RNA (Hathcock et al.,
2002). To investigate whether haploinsufficiency for telomer-
ase RNA leads to telomere shortening, we examined telo-
mere length by quantitative fluorescence in situ hybridization
(Q-FISH). CAST/EiJ mTR/ mice had significantly shorter
telomeres than wild-type. Furthermore, successive genera-
tions of CAST/EiJ mTR+/ heterozygous mice showed pro-
gressive telomere shortening (Figure 1B). The fact that the
telomeres in the heterozygotes were intermediate between
wild-type and mTR/ mice indicates that telomerase is
present and elongates some telomeres but the level is not
sufficient to maintain telomeres at wild-type lengths. The de-
crease in the mean telomere length was associated with an
increase in signal free ends (SFE) (Figure 1C). These signal
free ends represent dysfunctional telomeres and correlate
with cell death and chromosome rearrangements (Hemann
et al., 2001b). The progressive telomere shortening with later
generations ofmTR+/mice is similar to the phenomenon of
genetic anticipation that is seen in autosomal-dominant dys-
keratosis congenita (Vulliamy et al., 2004; Armanios et al.,
2005). This telomere shortening and the increase in signal
free ends further confirms that the CAST/EiJ mTR+/ mice
are haploinsufficient for telomere-length maintenance.
CAST/EiJ mTR/ and CAST/EiJ mTR+/ Mice
Show Tissue Renewal Defects
The CAST/EiJmTR/mice showed a dramatic decrease in
survival compared to wild-type animals (Figure 2A). Such
a reduction in survival was not seen in C57BL/6J mTR/
mice (Rudolph et al., 1999). Pathology examination revealed
intestinal lesions, which included severe depletion of the in-
testinal epithelial crypts and villus atrophy/loss in the smallc.
Figure 1. Breeding Scheme and Telomere-
Length Analysis
(A) Heterozygous generation 1mTR+/ (HG1) an-
imals were interbred to generate HG2, wt2*, and
mTR/ KO-G1. KO-G1 animals were inter-
crossed to generate KO-G2 offspring. Heterozy-
gous animals of the same generation were inter-
bred for five generations.
(B) Top panel: Q-FISH telomere-length analysis
of wild-type (black, n = 3) and KO-G1 (red,
n = 3) animals. The bottom panel shows telomere
length of HG1 (gray, n = 4) and HG5 (blue, n = 4)
animals. The histogram is truncated at 6600 fluo-
rescence units for clarity; the number of telo-
meres above this value is plotted at the end on
the far right. A Two-sample Wilcoxon rank-sum
test showed KO-G1 telomeres are significantly
shorter than wild-type (p < 0.0001) and HG1 telo-
meres are significantly shorter than HG5 telo-
meres (p < 0.0001).
(C) Histogram of the average number of signal
free ends (SFE) per metaphase from different an-
imals. Error bars are mean ± SEM. More than
seven metaphases were analyzed for each ani-
mal and results from multiple animals were
pooled for each genotype shown (n = 3 for
wild-type, n = 4 for HG1, n = 2 for HG2, n = 3
for HG3, n = 5 for HG4, n = 2 for HG6, and
n = 6 for KO-G1). The Q-FISH analysis was
scored in a blinded fashion.intestine. Histological sections of the large and small intes-
tines inmTR/G1 andG2 animals showedmultifocal to co-
alescing areas of crypt depletion. Villus atrophy was present
in the small intestine in 7 of 7 mTR/ mice (Figure 2C). The
atrophy occupied 19% of the small intestine (range 9%–
27%). In 4 of 7 mTR/ mice (57%), we also saw villus atro-
phy in the colon occupying 6% (range 5%–12%) (Figure 2F).
Microadenomas were present concurrently with the atrophic
lesion in all the mice examined (7 of 7). Villous atrophy and
microadenomas were not seen in wild-type mice (n = 9).
This degree of crypt depletion and small intestinal villus atro-
phy was significantly greater than seen in C57BL/6JmTR/
G5 mice (Herrera et al., 1999; Rudolph et al., 1999). The mi-
croadenomas of the intestinal epithelium are reminiscent of
the premalignant lesions of the oral epithelium, known as
leukoplakia, that occur in dyskeratosis congenita patients
andmay represent crypt dropout and compensatory prolifer-
ative lesions initiated by short telomeres. Finally, The CAST/
EiJ mTR/ mice also showed hypocellular seminiferous
tubules and a consequent decrease in testes weight due
to germ cell apoptosis as seen in C57BL/6J mTR/ miceCell 1(Hemann et al., 2001a). The reduced viability together with
the reduction in testes weight and increased aberrant semi-
niferous tubules resulted in small litter sizes and the inability
to generate mTR/ G3 mice.
The telomere shortening was substantial in late-genera-
tion CAST/EiJ mTR+/ heterozygous mice, and there were
a large number of signal free ends. To examine whether
the short telomeres in the heterozygotes were dysfunctional,
we examined testes sections from these mice. We found
germ cell hypoplasia/degeneration with empty seminiferous
tubules in the HG3 and HG4 mice (Figure 2D). Further signif-
icant crypt depletion and hyperplasia accompanied by villus
atrophy/loss were also seen in an HG5 mouse that showed
similar signs of illness to the mTR/ mice (Figure 2E) and
had significant telomere shortening (data not shown), sug-
gesting that the short telomeres also cause disease in these
animals. These phenotypic manifestations of telomere dys-
function in heterozygotes provide genetic evidence for hap-
loinsufficiency. Furthermore, the correlation of phenotypes
with short telomeres indicates that it is telomere length, not
a reduction in telomerase activity, that causes disease.23, 1121–1131, December 16, 2005 ª2005 Elsevier Inc. 1123
Figure 2. Phenotype Analysis of mTR/ and mTR+/ Animals
(A) Kaplan-Meier survival curve of the KO-G1, KO-G2, and wild-type animals shows a statistically significant decrease in survival in the null animals com-
pared to wild-type (p < 0.0001). The median survival for wild-type was 627 days, for KO-G1 it was 242 days, and for the KO-G2 it was 129 days.
(B) Kaplan-Meier survival curve of 10mTR/ KO-G1 animals that were derived from HG1 cross (green) and 10mTR/ KO-G1 animals that were derived
from HG3 cross (orange) shows significantly different survival (p = 0.0153). The median survival for KO-G1 from HG1 crosses was 247 days and for the
KO-G1 animals from HG3 crosses it was 192 days.
(C) H&E section of small intestine. Normal crypts (arrowheads) and villi (arrow) in the wild-type control in the left panel. The middle panel shows an area of
severe crypt depletion and villus atrophy. The right panel shows a microadenoma (arrow) with an adjacent area of small intestine with crypt depletion and1124 Cell 123, 1121–1131, December 16, 2005 ª2005 Elsevier Inc.
The Reduced Survival of CAST/EiJ mTR/ Mice
Shows Anticipation
Autosomal-dominant dyskeratosis congenita shows genetic
anticipation, presumably due to the inheritance of short telo-
meres that get shorter with each generation (Vulliamy et al.,
2004). This anticipation implies that CAST/EiJ mTR/ null
animals that are derived from late-generation heterozygotes
may have more severe phenotypes than those from early
generations. To examine this, we looked at the survival of
CAST/EiJ mTR/ mice that came from crosses of either
HG1 or HG3 parents (Figure 2B). We found a significant re-
duction in the life span of mTR/ animals whose parents
were HG3 compared to themTR/ animals whose parents
were HG1. Thus, the inheritance of short telomeres from het-
erozygous parents contributes to the worsening of pheno-
types in the offspring, which leads to premature death.
This is the hallmark of genetic anticipation.
Hematopoietic Dysfunction in CAST/EiJ mTR+/
Mice Correlates with Short Telomeres
Autosomal-dominant dyskeratosis congenita patients have
impaired hematopoietic function that often leads to death
due to bone marrow failure. Histological examination of the
bone marrow in the mTR/ G1 and G2 mice showed nor-
mal cellularity and morphology but with a skewed myeloid
to erythroid ratio of 5:1 (normal 2.5:1; Sanderson and Phil-
lips, 1981). There was also extensive extramedullary hema-
topoiesis in the liver, spleen, and kidney (data not shown)
in the mTR/ animals, indicating that the mice had ineffec-
tive bone marrow hematopoiesis. To further evaluate bone
marrow function inmTR/ andmTR+/mice, we examined
peripheral blood through complete blood counts (CBC).
There was a reduction in peripheral white blood cell, platelet,
and red blood cell numbers in each successive generation of
heterozygous mice, and these counts were significantly be-
low the lower normal limits in mTR+/ HG4 (Figure 3B).
Telomere-length heterogeneity leads to significant mouse-
to-mouse variation in mean telomere length (Herrera et al.,
1999; Hemann et al., 2001b). To more directly examine the
role of telomere shortening in the reduced blood counts,
we examined telomere length by Q-FISH in individual mice
that were used for the peripheral blood counts described
above. Short telomeres were tightly correlated with reduced
white cell, platelet, and red cell counts (Figure 3A). In fact, the
correlation of reduced CBC with telomere length was better
than the correlation with increasing heterozygous generation
(Figure 3A). Thus it is the short telomeres, not the absence,Celor lower levels of telomerase that cause the reduction in he-
matopoietic function.
CAST/EiJ Heterozygotes with Short Telomeres
Are Sensitive to Chemotherapy
A decrease in marrow reserves canmanifest as an increased
sensitivity to cytotoxic agents. We thus examined the re-
sponse to the chemotherapeutic agent 5-fluorouracil
(5-FU). 5-FU is cytotoxic to cells in S phase, and efficient re-
covery from treatment reflects the number and function of
progenitor cells in the affected tissues. Total white blood
cell counts were measured in wild-type, mTR+/ HG5, and,
mTR/ G1 mice before injection with 5-FU. White blood
cell counts were then monitored on day 6 and day 13 after
injection (see Experimental Procedures). All mice showed
a significant reduction in white counts 6 days after injection,
as expected. However, mTR+/ HG5 mice had lower white
counts on day 13 than the wild-type mice (Figure 3B).
mTR/ animals had the lowest white counts on day 6 and
day 13 as compared to heterozygous and wild-type animals.
This indicates that the capacity to sustain and recover from
the stress of 5-FU treatment is compromised by limited
bone marrow reserves. This general decrease in progenitor
reserves due to short telomeres may reflect the sensitivity
seen in dyskeratosis congenita patients to chemotherapy
and to bone marrow transplant preparative regimens (Yabe
et al., 1997; Rocha et al., 1998).
Bone Marrow from Mice with Short Telomeres
Is Inefficient at Hematopoietic Reconstitution
To examine the function of the hematopoietic precursor pool
directly, we used a hematopoietic reconstitution assay (Mor-
rison et al., 1995) (Figure 4). Donor bone marrow, isolated
from CAST/EiJ wild-type, mTR/ G1, and mTR+/ HG5
mice, was injected into lethally irradiated CAST/EiJ wild-
type mice (see Experimental Procedures). Irradiated mice
that received no donor cells died within 20 days after irradi-
ation. All mice reconstituted with marrow from wild-type do-
nors lived for over 150 days. Mice reconstituted with marrow
from CAST/EiJ mTR/ G1 donors had a median survival of
53 days, and those reconstituted with CAST/EiJ mTR+/
HG5 donor marrow had a median survival of 64 days. This
diminished capacity of both the mTR/ and mTR+/ mar-
row to reconstitute effectively the hematopoietic system of
irradiated mice indicates a functional reduction in the hema-
topoietic cell precursor pool.villus atrophy/loss (arrowheads). The microadenoma had areas with mild dysplasia of intestinal epithelial cells (inset, arrows). All animals were age matched.
The slides were read in a blinded fashion.
(D) Decreased testes weight and increased aberrant testicular tubules found in the KO and heterozygous animals. Top panel shows the percent aberrant
tubules found in each genotype (n = 5 for wild-type, 7 for G1, 2 for G2, and 8 for HG3). Bottom panel shows the testes weight for each animal (n = 9 for wild-
type, 4 for G1, 2 for G2, and 9 for HG3). Error bars are mean ± SEM. ## indicates p value of less than 0.05 using Student’s t test.
(E) GI tract defect inmTR+/HG5 animal observed in the small intestine (top panels) and large intestine (bottom panels). The wild-type controls are shown to
the left. The top right shows crypt proliferation (arrow) with adjacent areas of crypt depletion in the small intestine. The bottom left panel shows normal colon
(left) with colonic crypts (arrowheads) and flat intercrypt table surface epithelium. The bottom right image shows an irregular intercrypt table epithelial surface
and hyperplasia of colonic crypts (arrow) in the HG5 mouse. Scale bars represent 50 mm.
(F) Quantitation of the percent of villous atrophy from large and small intestines from wild-type (n = 9), HG3-HG5 (n = 10), and KO-G1 (n = 7) animals from
H&E sections shows more severe atrophy in the heterozygous as well as the KO-G1 animals compared to wild-type controls.l 123, 1121–1131, December 16, 2005 ª2005 Elsevier Inc. 1125
Figure 3. Hematological Defects
(A) White blood cell, platelet, and red blood cell
counts were analyzed in HG1, HG2, HG3, HG4,
HG5, and HG6 mice. A total of 13 animals were
analyzed. The counts in each mouse are shown
as a dot and the decrease with each generation
is shown as a regression line (left panels). The
p value for white blood cells, platelet, and red
blood cells are 0.1585, 0.0012, and 0.487, re-
spectively. The panels on the right show theblood
cell counts plotted relative to the mean telomere
length of the individual animal. Due to animal-to-
animal variation there is a better correlation of
short telomeres with reduced blood counts than
the correlation with heterozygous generation.
The p value for white blood cells, platelet, and
red blood cells are 0.0473, 0.0003, and 0.3041,
respectively.
(B) The peripheral white blood cell count from
wild-type (wt) and HG4 and mTR/ G1 (KO)
were analyzed before 5-FU injection and 6 and
13 days after injection. Error bars are mean ±
SEM.wt* Animals Derived from mTR+/ Parents Have
Short Telomeres and Occult Disease
The genetic anticipation and progressive telomere shorten-
ing in the CAST/EiJ mTR+/ mice suggested that wild-type
mice might also inherit short telomeres. To examine this di-
rectly, we measured by Q-FISH telomere length from all ge-
notypes derived from intercrossing CAST/EiJ mTR+/ HG4
mice. Surprisingly, we found that the telomere length of the
wild-type pups was shorter than from wild-type animals
whose ancestors had never been deficient for telomerase.
This suggests that one generation in the presence of wild-
type levels of telomerase is not sufficient to restore telomeres1126 Cell 123, 1121–1131, December 16, 2005 ª2005 Elsevier Incto wild-type length. Since these mice were not identical to
wild-type, we designated these mice as wt*. Wt* mice that
were generated from CAST/EiJ mTR+/ HG4 parents were
designated wt5* to correspond with theirmTR+/ HG5 litter-
mates and to indicate the number of generations the parents
were heterozygous. Correspondingly, wild-type mice from
HG3 parents were designated wt4* (Figure 5A). We exam-
ined three independent mouse families from HG3 and HG4
parents to compare telomere lengths in the littermate pups
of different genotypes. In each of the families studied, the
telomeres in the wt* mice were shorter than those of the
true wild-type CAST/EiJ animals obtained from The Jackson.
Laboratory (Figure 5B). Telomere lengths of the heterozy-
gous littermates were shorter still, and finally the null animals
showed the shortest telomeres. Thus the level of telomerase
present had some effect on telomere length, indicating that
telomerase is limiting, but having a full complement of telo-
merase for one generation was not sufficient to restore telo-
meres to the proper length.
The fact that the wt5* had short telomeres suggested that
there may be telomere dysfunction in these animals. To test
this directly, we examined testes weight and found a signifi-
cant reduction in the wt4* mice compared to wild-type mice
(Figure 5D). Histological examination showed evidence of
germ cell hypoplasia/degeneration with empty seminiferous
tubules in the wt4* mice (Figure 5C). This loss of germ cells in
the wt4* mice indicates that short telomeres, which were in-
herited from the heterozygous parents, can exhibit telomere
dysfunction even in the presence of wild-type levels of telo-
merase. Further, it indicates that genetic disease can be
present in animals that are genetically wild-type. Thus, we
refer to this surprising result as hidden, or occult, genetic
disease.
DISCUSSION
Patients with autosomal-dominant dyskeratosis congenita
and aplastic anemia, caused by heterozygous mutations in
telomerase components, exhibit bone marrow failure due
to the loss of hematopoietic stem cells. In a formal, genetic
sense, haploinsufficiency for telomerase causes the disease.
However, the CAST/EiJ mTR+/ mouse model described
here shows that although the ability of telomerase to main-
tain telomere length depends on telomerase dosage, it is
not the amount of telomerase but rather the short telomeres
themselves that cause stem cell failure. The fact that telo-
mere length is the prime determinant of phenotype is dem-
onstrated by the fact that short telomeres can cause pheno-
Figure 4. Bone Marrow Transplantation
CAST/EiJ recipient mice were irradiated and injected with marrow from
HG5, KO-G1, andwild-type animals.Wild-type bonemarrow fully rescued
viability in recipients for more than 100 days (n = 4) whereas the knockout
donor cells was deficient in rescuing viability (n = 4, p = 0.0067when com-
pared to wild-type using Log-rank test). The heterozygous donor cells
partially rescued (n = 7, p = 0.1041 when compared to wild-type using
Log-rank test). The unreconstituted control animals (labeled as None)
died within 3 weeks after irradiation (n = 5).Celtypes even in wild-type animals. The ability of short telomeres
to limit cellular renewal has implications for patients with dys-
keratosis congenita. In addition, the fact that short telomere
can cause phenotypes even in wild-type animals has impli-
cations for normal individuals who inherit short telomeres;
it suggests that short telomeres can contribute to stem cell
loss and can limit tissue renewal capacity.
Possible Mechanisms for Loss of Function
at Short Telomeres
There are a number of mechanisms that have been pro-
posed for how telomeres become dysfunctional in cells
that lack telomerase. Two models suggest that the telome-
rase enzyme may function directly in telomere end protection.
First the ability of yeast telomerase to remain bound to telo-
meric primers in vitro led to the proposal that telomerase
binds to and protects telomeres (Prescott and Blackburn,
1997; Blackburn, 2000). More recently it has been proposed
that telomerase is required to synthesize the G-strand over-
hang at telomeres that is essential for telomere end protec-
tion. It has also been suggested that the loss of G-strand
overhangs is responsible for the telomere-mediated senes-
cence in human fibroblasts (Masutomi et al., 2003; Stewart
et al., 2003). However, a G-strand overhang is still present
in C57BL/6J mTR/ G6 mice with very short telomeres
(Hemann and Greider, 1999). Further, we show here that
telomere function is lost on short telomeres even in the pres-
ence of telomerase in both the CAST/EiJmTR+/ and the wt*
mice. This indicates that that telomerase itself does not play
a direct role in the protection of telomeres; short telomeres
are dysfunctional even when normal telomerase activity is
present.
Understanding that it is short telomeres, not the absence
of telomerase, that causes telomere dysfunction limits the
possible mechanisms that may cause the dysfunction. The
simple loss of all telomeric repeats may initiate the damage
response that leads to cell death or senescence. Alterna-
tively, very short tracts of telomeric repeats may fail to bind
the essential telomere binding proteins that protect telo-
meres and distinguish them from DNA breaks (Smogor-
zewska and de Lange, 2004). Finally, telomeres in many or-
ganisms form T loops in which the single-stranded G-strand
30 tail is looped around and base paired in the double-
stranded telomere sequence (Griffith et al., 1999). Very short
telomeres are predicted not to form these T loops and may
thus signal DNA damage by failing to form this protective
end structure (de Lange, 2002).
Telomerase Dosage Affects the Maintenance
of Telomere Length
The short telomeres and the genetic anticipation seen in
autosomal-dominant dyskeratosis congenita families indicate
that insufficient telomerase activity causes progressive telo-
mere shortening. Autosomal-dominant dyskeratosis conge-
nita can result from null alleles of hTR or hTERT that show
loss of function in vitro, suggesting that a simple decreased
dosage of functional telomerase causes telomere shortening
(Armanios et al., 2005; Marrone et al., 2005). In our studies,
the CAST/EiJ mTR+/ mice show progressive telomerel 123, 1121–1131, December 16, 2005 ª2005 Elsevier Inc. 1127
Figure 5. Occult Genetic Disease in wt*
(A) The breeding scheme to derive wt5* animals.
(B) Telomere-length analysis using Q-FISH in three mouse families. Top panel: wild-type telomere lengths are from animals obtained directly from The Jack-
son Laboratory. The HG5, wt5*, and KO are three littermates from a HG4 cross. Middle panel: the HG4 and wt4* littermates from a HG3 cross are shown.
Bottom panel: the HG5, wt5*, and KO are three littermates from a HG4 cross.
(C) H&E section of control wt (upper) and wt4* (lower) testes showing aberrant tubules with degeneration/hypoplasia of germ cell epithelium (arrows).
GC = germ cell epithelium; ST = seminiferous tubule.
(D) Left panel: the percent aberrant tubules seen in histological sections from wt* animals (n = 4) and wt (n = 5). Right panel: the testes weight of wt* (n = 9)
andwt control animals (n = 6). Error bars aremean ± SEM. ## indicates a p value of less than 0.05 using Student’s t test. The analysis was scored in a blinded
fashion.1128 Cell 123, 1121–1131, December 16, 2005 ª2005 Elsevier Inc.
shortening with each generation of interbreeding. This dem-
onstrates that half of the level of telomerase is not sufficient to
maintain the telomere distribution at the wild-type equilib-
rium length. While the breeding scheme we used in crossing
mTR+/ mice to each other simplifies the telomere-length
analysis, in human families, only one parent may carry the
hTR/hTERT hypomorphic or null allele. Thus the rate of telo-
mere shortening across generations in autosomal-dominant
dyskeratosis congenita families is expected to be slower.
The level of the catalytic TERT protein also shows a dosage
effect on telomere-length maintenance in mice (Erdmann
et al., 2004). This inability of reduced levels of telomerase
to maintain the telomere-length equilibrium is surprising.
In vitro telomerase is very efficient, and in yeast in vivo elon-
gation of only a few telomeres at each division is sufficient to
maintain homeostasis of the telomere-length distribution
(Teixeira et al., 2004). Further, the shortest telomeres in the
length distribution are preferentially elongated by telomerase
(Hemann et al., 2001b; Teixeira et al., 2004). This implies
that, for disease to arise, the number of short dysfunctional
telomeres must overwhelm the limiting amount of telome-
rase. This requirement for many short telomeres for disease
to bemanifest may explain why phenotypes were not seen in
the C57BL/6J mTERT+/ mice despite telomere shortening
(Erdmann et al., 2004). The very broad distribution of telo-
mere lengths in C57BL/6J mice means that, at any given
time, there are very few short telomeres that may not be
sufficient to signal dysfunction. In contrast, the CAST/EiJ
mouse has a much narrower telomere-length distribution,
so shortening of this distribution results in a significantly
higher fraction of short telomeres. The number of short dys-
functional telomeres eventually exceeds the number that can
be elongated by telomerase during each cycle.
Short Telomeres Limit Tissue Renewal
Although telomerase dosage affects telomere-length distri-
bution, it is the short telomeres that determine disease phe-
notype. This is evident from the wt* mice that inherit short
telomeres and show telomere dysfunction in the presence
of wild-type levels of telomerase. This form of occult genetic
disease has not been documented with any other type of ge-
netic change. Since short telomeres are inherited in humans
(Graakjaer et al., 2004), this phenotypic manifestation of telo-
mere dysfunction, in the absence of any overt mutation, may
occur in families with autosomal-dominant dyskeratosis
congenita, or even in individuals with short telomeres without
a family history of disease (see below). This fact has im-
portant clinical implications; for example, aplastic anemia
is sometimes treated with bone marrow transplant, often
from an unaffected relative. In families with telomerasemuta-
tions however, a relative may not have a mutation but may
have short telomeres. Such wt* individuals may not be a
good choice for a bone marrow donor as their stem cell
pool may be limited. Our data also suggest that bonemarrow
donors with long telomeres may be preferable for transplant
where it is possible. The availability of reliable clinical assays
for telomere length would greatly facilitate the classification
of donor telomere lengths. Second, patients with dyskerato-
sis congenita are often exquisitely sensitive to certain cyto-Celltoxic bone marrow preparative regimens. Knowing whether
an individual has short telomeres and possibly decreased
bone marrow reserves may predict toxicities to treatment
and therefore be relevant to treatment decisions. Finally, in
diagnosing dyskeratosis congenita, telomere length should
be examined even if mutations in hTR or hTERT are not pres-
ent because some individuals may be wt*. Given that it is
telomere length, not the presence or level of telomerase,
that causes disease, it is possible that mutations in other
genes that affect telomere length lead to disease. There
are a large number of proteins that are involved in the main-
tenance of telomere length (Smogorzewska and de Lange,
2004). It will be interesting to determine if mutations in these
genes play a role in other forms of dyskeratosis congenita for
which no genetic changes have yet been identified (Marrone
et al., 2005).
Implications of wt* Mice for Telomere Effects
on Human Age-Related Disease
The loss of telomere function on short telomeres in wt* mice
has implications for the role of short telomeres in disease
states in normal individuals. The variation in telomere length
within the population and possibly also individual variation in
the expression of telomerase components may lead to telo-
mere dysfunction in normal individuals. The particular organ
system that is affected may depend on environmental fac-
tors that increase turnover in a particular tissue in one individ-
ual. Short telomeres do in fact correlate with an increased
risk of mortality due to age-related disease (Cawthon et al.,
2003; Valdes et al., 2005). The evidence presented here
that, irrespective of telomerase levels, it is the short telo-
meres that are the primary determinant of disease implies
that individuals with short telomeres but no family history of
mutations in telomerase may be predisposed to defects in
tissue renewal capacity. These effects are more likely to
appear in tissues of high turnover such as the bone marrow
or gastrointestinal tract where stem cell function may be lim-
iting. Since stem cell failure has been linked to aging (Tyner
et al., 2002), subtle defects in telomere function that affect
stem cell renewal potential may predispose to age-related
disease.
EXPERIMENTAL PROCEDURES
Mouse Breeding and Colony
CAST/EiJ mice were purchased from The Jackson Laboratory (Maine).
We initially backcrossed the null mTR allele from the C57BL/6 back-
ground onto the CAST/EiJ background for five generations. These het-
erozygous animals after five backcrosses were designated CAST/EiJ
HG1 for heterozygous generation 1. Interbreeding of HG1 generated
KO-G1, HG2, and wt2* as indicated in Figure 1. HG2 crosses generated
KO-G1, HG3, and wt3*. Interbreeding of the mTR/ KO-G1 gave
mTR/ KO-G2 animals.mTR/ KO-G2 animals were always generated
frommTR/ KO-G1 that came out of the same heterozygous generation
breeding. To generate more HG1 animals, HG1 animals were bred to
wild-type mice purchased from The Jackson Laboratory and the hetero-
zygous pups were treated as HG1 animals. All animals were housed and
bred in the pathogen-free environment at The Johns Hopkins University.
All procedures were approved by the Institutional Animal Care and Use
Committee at The Johns Hopkins University.123, 1121–1131, December 16, 2005 ª2005 Elsevier Inc. 1129
Quantitative FISH
Splenocytes were used to generate metaphases for Q-FISH as described
(Hemann et al., 2001b). In short, the spleen was isolated and a single-cell
suspension obtained using a cell strainer (BD Falcon) and cultured in
RPMI Medium 1640 (Invitrogen) with 10% fetal bovine serum (Invitrogen),
1% Pen/Strep/Glu (Invitrogen), 1% HEPES (Invitrogen), and 1%MEM So-
dium Pyruvate (Invitrogen). Cells were stimulated with 1 mg LPS (Sigma),
25 Cu/ml IL2 (Roche), and 5 mg/ml Con A (Sigma) for 40–48 hr at 37ºC
with 5% CO2 prior to colcemid arrest (10 mg/ml, Invitrogen) for 30 min
at 37ºC. Cells were treated with hypotonic solution containing 0.4% KCl
for 4 min at 37ºC and then fixed with 3:1 Methanol:Acetic Acid fixative.
Cells were washed with fixative six times and then metaphases were
dropped. Slides were chilled at 4ºC overnight and then hybridized for
Q-FISH with Cy3-labeled PNA telomere probe (Applied Biosystems). All
the Q-FISH analysis was done as a blind study in which the genotype
of the animals was not known to the person performing the analysis.
Statistical Tests and Survival Curves
TheWilcoxon rank sum test for the telomere-length analysis and the linear
regression of CBC were calculated in the STATA 8.0 program. Animals
used for Kaplan-Meier survival curve were set aside at weaning age
according to their genotype. Animals were closely monitored daily and
sacrificed when signs typical of terminal illness in this colony appeared.
Kaplan-Meier curves were generated using STATA 8.0 program and
p values were obtained using log-rank test.
Bone Marrow Transplantation
CAST/EiJ recipient wild-type mice (Jackson Laboratory) were irradiated
with 10Gy using GammaCell 40 (Cs137 source) irradiator. To prepare do-
nor cells, bone marrow was isolated from femurs and tibias from donor
animals by flushing with PBS using a 23G needle (BD Falcon). Cell
were counted with a hemocytometer and resuspended to 5  106 per
ml of PBS. 1 106 cells were injected into the tail vein of irradiated recip-
ients. Unreconstituted animals died within 2–3 weeks after irradiation. Re-
constituted animals were monitored on a daily basis to generate the
Kaplan-Meier survival curve shown in Figure 2.
Histology
Organs were fixed in 10% buffered formalin as soon as animals were sac-
rificed. GI tract and airway were infused with 10% formalin to preserve the
architecture of the organs. Fixed organs were then embedded in paraffin,
sectioned at 5 mm, and stained with H&E. For testes analysis, testes were
fixed in Bouin’s fixative for 3 days and similarly processed and sectioned.
Slides were evaluated for aberrant tubules in blinded fashion where the
genotype of the animal was not known to the person doing the analysis.
Complete Blood Count
Animals were anesthetized and heart puncture was performed immedi-
ately. Blood was drawn into EDTA coated tubes (BD) and sent to Antech
Diagnostics for complete blood count on the same day.
5-FU and Peripheral Blood Counts
Age-matched animals were used for 5-FU experiment. 5-FU was pur-
chased from Sigma and resuspended into 20 mg/ml PBS. Animals
were weighed and 150 mg of 5-FU per kg of body weight was given
intraperitoneally (Rudolph et al., 1999). Fifty microliters of blood was col-
lected through tail vein every week into EDTA containing tubes (BD). Pe-
ripheral white blood cell counts were obtained by diluting 10 ml of whole
blood into 190 ml of red blood cell lysing reagent (388 mM NH4Cl,
29.7 mM NaHCO3, 25 mM Na2EDTA), and the number of white cells
was counted using a hemocytometer.
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